Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Thyroid cancer
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== '''Follicular thyroid cancer (differentiated)''' === ** '''Epidemiology''' *** 11% of all thyroid cancer *** Peak incidence 40-60yo *** Female 3:1 ** '''Risk factors''' *** Main risk is iodine deficiency *** Cowden syndrome, Carney complex, Werner syndrome *** Family history DTC - familial non-MTC *** Obesity ** '''Pathophysiology''' *** Cytological features are quire variable - FNA will be reported as follicular neoplasm, Hurthle cell neoplasm, or follicular lesion of undetermined significance - but to actually diagnose FTC you need to show invasive nature (vascular or capsule invasion) *** Molecular genetics **** RAS mutations 30-40% (NRAS -> HRAS -> KRAS) **** PAX8/PPARy fusion 20-30% *** Diagnostic lobectomy is often required, with subsequent completion thyroidectomy if cancer is confirmed. *** Risk of cancer increased in follicular/Hurthle cell neoplasms >4cm, so up-front total thyroidectomy may be preferred in these cases *** Frozen section not useful for intra-operative diagnosis of FTC *** Spreads haematogenously to lungs, liver, brain and bone, with <10% having regional lymph nodes *** Hurthle cell carcinoma is generally considered to be a subtype of FTC **** Distinguished from FTC by presence of oxyphilic Hurthle (or oncocytic) cells - characteristic cellular enlargement with abundant eosinophilic granular cytoplasm, due to an increased number of mitochondria **** Distinct and more aggressive behaviour **** Peak incidence 50-70yo **** Metastasises via both blood and lymph, present at diagnosis in 20% of patients **** 38% are RAI-avid, which is less than other DTCs
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Thyroid cancer
(section)
Add topic